Literature DB >> 322781

The fate of biogenic monoamines in perfused rabbit lung.

C N Gillis, J A Roth.   

Abstract

1. Inactivation of beta-phenylethylamine and several of its derivatives was studied in a preparation of rabbit lung perfused with Krebs physiological medium at 37 degrees C. Inactivation or removal of these compounds was calculated as the difference between the concentration of each amine in the perfusion medium and the effluent, collected separately from each lung. The extent of amine metabolic degradation was also measured, by column chromatography, in lung effluent. 2. With this technique the magnitude of amine removal as a function of concentration was determined and an apparent Km and Vmax of removal were calculated for each amine. 3. Percentage removal was highest with phenylethylamine (95%), and decreased, apparently in relation to increasing phenyl- and side chain-hydroxylation (and therefore likely increased hydrophilicity), and 5-hydroxytryptamine (64%), tyramine (53%), octopamine (35%), dopamine (32%) and noradrenaline (23%). 4. Inactivation of each amine could be accounted for by metabolic degradation to deaminated products, which appeared in lung effluent within 90 s of beginning amine perfusion. 5. When intrapulmonary metabolism of phenylethylamine was inhibited by simultaneous perfusion with semicarbazide (10 mM) and pargyline (10 micronM), the removal rate was unaltered, establishing that uptake of the amine from the vascular space is not dependent on metabolism at least for 4 min infusions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 322781      PMCID: PMC1667755          DOI: 10.1111/j.1476-5381.1977.tb07725.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

Review 1.  Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs.

Authors:  N H Neff; H Y Yang
Journal:  Life Sci       Date:  1974-06-01       Impact factor: 5.037

Review 2.  Pharmacokinetic function of the pulmonary circulation.

Authors:  Y S Bakhle; J R Vane
Journal:  Physiol Rev       Date:  1974-10       Impact factor: 37.312

3.  Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.

Authors:  J A Roth; C N Gillis
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

4.  Site and mechanism of uptake of 3H--norepinephrine by isolated perfused rat lungs.

Authors:  T E Nicholas; J M Strum; L S Angelo; A F Junod
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

5.  The removal of noradrenaline in the pulmonary circulation of rat isolated lungs.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

6.  Technique for measurement of norepinephrine and 5-hydroxytryptamine uptake by rabbit lung.

Authors:  C N Gillis; Y Iwasawa
Journal:  J Appl Physiol       Date:  1972-09       Impact factor: 3.531

7.  Free pulmonary passage of dopamine.

Authors:  J C Boileau; C Crexells; P Biron
Journal:  Rev Can Biol       Date:  1972-03

8.  Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs.

Authors:  A F Junod
Journal:  J Pharmacol Exp Ther       Date:  1972-11       Impact factor: 4.030

9.  Metabolism of phenylethylamine in rat isolated perfused lung: evidence for monoamine oxidase 'type B' in lung.

Authors:  Y S Bakhle; M B Youdim
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

10.  Multiple forms of amine oxidase in perfused rabbit lung.

Authors:  J A Roth; C N Gillis
Journal:  J Pharmacol Exp Ther       Date:  1975-09       Impact factor: 4.030

View more
  9 in total

1.  Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.

Authors:  N J Paczkowski; H E Vuocolo; L J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

Review 2.  Role of the lung in total body clearance of circulating drugs.

Authors:  R A Roth; D A Wiersma
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

3.  The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro.

Authors:  Y S Bakhle; M B Youdim
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

4.  The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines.

Authors:  B Friedgen; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

5.  [Expression of angiotensin I converting enzyme in pulmonary hypertension].

Authors:  A M Müller; M Maas; U Kozianka; F E Franke
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

6.  A kinetic investigation of the pulmonary metabolism of dopamine in rats shows marked differences compared with noradrenaline.

Authors:  D L Scarcella; L J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

7.  Dopamine and adrenaline, but not isoprenaline, are substrates for uptake and metabolism in isolated perfused lungs of rats.

Authors:  L J Bryan-Lluka; S R O'Donnell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

8.  [Angiotensin converting enzyme (ACE, CD143) in the regular pulmonary vasculature].

Authors:  A M Müller; K Gruhn; S Lange; F E Franke; K-M Müller
Journal:  Pathologe       Date:  2004-03       Impact factor: 1.011

9.  Evidence for saturation of catechol-O-methyltransferase by low concentrations of noradrenaline in perfused lungs of rats.

Authors:  L J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.